| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/13/2007 | CA2640573A1 Process for preparing a crystalline form of atorvastatin hemi-calcium |
| 09/12/2007 | EP1831238A2 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides |
| 09/12/2007 | EP1831163A2 Method for producing pyrrolidones from succinates from fermentation broths |
| 09/12/2007 | EP1831159A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831149A1 Novel ligands that modulate rar receptors and use thereof in human medicine and in cosmetics |
| 09/12/2007 | EP1830841A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1613304B1 Dpp-iv inhibitors |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1019358B2 3,3-diarylpropylamines , their use and preparation |
| 09/12/2007 | CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 09/12/2007 | CN101035757A Stabilizers for use in NVP synthesis |
| 09/12/2007 | CN101035526A Ophthalmic compositions for treating ocular hypertension |
| 09/12/2007 | CN101033250A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 09/12/2007 | CN101033209A Method of preparing pharmaceutical intermediate of (2S,4R)-4-hydroxy-N,N-dimethyl-2-pyrrolidineformamide |
| 09/12/2007 | CN100336805C Chiral sulfonamide-aminol ligand and preparation method and uses |
| 09/12/2007 | CN100336794C N-arylation process with hydrazone as ligand in aqueous phase system |
| 09/11/2007 | US7268236 Method of heightening optical purity of 1-benzyl-3-aminopyrrolidine and salt for used therein |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 09/11/2007 | US7268158 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | CA2432064C Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/11/2007 | CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers |
| 09/11/2007 | CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 09/07/2007 | WO2007100086A1 Ligand, method for producing the same, and catalyst using the ligand |
| 09/07/2007 | WO2007099934A1 Aliphatic amino acid labeled with stable isotope, method of inserting the same in target protein, and method of nmr conformation analysis of protein |
| 09/07/2007 | WO2007099894A1 General-purpose deprotecting method using sulfur oxide |
| 09/07/2007 | WO2007099552A2 Novel crystalline form of atovastatin hemi-magnesium |
| 09/07/2007 | WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions |
| 09/07/2007 | WO2007098597A1 Glycosidase inhibitors and methods of synthesizing same |
| 09/07/2007 | WO2007057703B1 Intermediate compounds for the preparation of statins |
| 09/07/2007 | CA2679271A1 Glycosidase inhibitors and methods of synthesizing same |
| 09/07/2007 | CA2644665A1 Ligand, method for producing the same, and catalyst using the ligand |
| 09/07/2007 | CA2643994A1 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 09/06/2007 | US20070208181 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208088 Pqs: a new hydrotrope for solubilizing lipophilic compounds in water |
| 09/06/2007 | US20070208055 Alternative synthesis of renin inhibitors and intermediates thereof |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208006 For treatment of behavioral disorders associated with dementia, psychoses |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207968 Peptidomimetic Inhibitors Of Retroviral Proteases And Their Use As Antivirals |
| 09/06/2007 | US20070207527 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors |
| 09/05/2007 | EP1829865A2 Chemical compounds |
| 09/05/2007 | EP1829861A2 Pyrrolidine ester derivatives active as oxytocin antagonists |
| 09/05/2007 | EP1828258A1 N-substituted imides as polymerization initiators |
| 09/05/2007 | EP1828172A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 09/05/2007 | EP1828122A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 09/05/2007 | EP1828121A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 09/05/2007 | EP1828120A1 Improved process for the preparation of (s)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| 09/05/2007 | EP1828119A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 09/05/2007 | EP1828118A1 Parp inhibitors |
| 09/05/2007 | EP1828117A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 09/05/2007 | EP1828116A1 Pyrrolidine compounds |
| 09/05/2007 | EP1828106A2 Methamphetamine derivatives and conjugates for immunoassay |
| 09/05/2007 | EP1828099A1 Synthetic process for aminocyclohexyl ether compounds |
| 09/05/2007 | EP1828082A1 Method for cleaning deposits from equipment that have accumulated during a method for recovering nmp, by the introduction of hot water and agitation |
| 09/05/2007 | EP1567490A4 Anti-sickling agents |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | CN101031564A Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029016A Dibasic or tribasic N-acyl-2,3-pyrroline compound and its synthesis |
| 09/05/2007 | CN100335468C Diaryl amidine compound, its production, medicinal composition and use |
| 09/04/2007 | US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265224 Red luminescent compound and organic electroluminescent device using the same |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265145 Bone disorders; osteoporosis; Paget's disease |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | CA2397828C Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007096903A2 New crystalline form of atorvastatin hemi-calcium |
| 08/30/2007 | WO2007096058A1 Cycloalkylphenyl substituted cyclic ketoenols |
| 08/30/2007 | WO2007095980A1 Modified amino acids |
| 08/30/2007 | WO2007095851A1 Unsaturated 5-member heterocycle compounds, uses and preparation methods theirof |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203218 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203201 Substituted anthranilamides for controlling invertebrate pests |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203111 Cycloalkylamines as monoamine reuptake inhibitors |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
| 08/30/2007 | DE102006007882A1 Cycloalkyl-phenylsubstituierte cyclische Ketoenole Cycloalkyl-substituted cyclic ketoenols |
| 08/30/2007 | CA2642787A1 Cycloalkylphenyl substituted cyclic ketoenols |
| 08/30/2007 | CA2642762A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/29/2007 | EP1826199A1 Modified amino acids |
| 08/29/2007 | EP1824841A1 Substituted pyrrole derivative |
| 08/29/2007 | EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 08/29/2007 | EP1824819A1 Pyrrolidin-2-one derivatives for use as dp1 receptor agonists |
| 08/29/2007 | CN101027312A 抗病毒化合物 Antiviral compounds |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027283A 3,4-disubstituted maleimides for use as vascular damaging agents |